These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 20127615
1. Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations - benchmarking instruments for international multicentre trials. Rösler M, Retz W, Stieglitz RD. Pharmacopsychiatry; 2010 May; 43(3):92-8. PubMed ID: 20127615 [Abstract] [Full Text] [Related]
2. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. Rösler M, Retz W, Fischer R, Ose C, Alm B, Deckert J, Philipsen A, Herpertz S, Ammer R. World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312 [Abstract] [Full Text] [Related]
10. Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability The use of Conners' Adult ADHD Rating Scales (CAARS). La Malfa G, Lassi S, Bertelli M, Pallanti S, Albertini G. Res Dev Disabil; 2008 Sep; 29(2):158-64. PubMed ID: 17416484 [Abstract] [Full Text] [Related]
11. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Fallu A, Richard C, Prinzo R, Binder C. Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338 [Abstract] [Full Text] [Related]
13. [Utility of the Wender-Utah rating scale and the checklists for the diagnosis of familial attention deficit hyperactivity disorder in adults. Convergent and concurrent validities]. Pineda DA, Trujillo-Orrego N, Aguirre-Acevedo DC, Arango CP, Hincapié-Henao L, Montoya-Arenas DA, Lopera F, Pineda-Alvarez DE, Arcos-Burgos M, Muenke M. Rev Neurol; 2006 Dec; 50(4):207-16. PubMed ID: 20198592 [Abstract] [Full Text] [Related]
18. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L. Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134 [Abstract] [Full Text] [Related]
19. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Depress Anxiety; 2009 Dec; 26(3):212-21. PubMed ID: 19194995 [Abstract] [Full Text] [Related]
20. Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program. Hesslinger B, Tebartz van Elst L, Nyberg E, Dykierek P, Richter H, Berner M, Ebert D. Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):177-84. PubMed ID: 12242579 [Abstract] [Full Text] [Related] Page: [Next] [New Search]